Three Reasons Why Quant (QNT) Surges 50% in September
Gamza Khanzadaev Quant (QNT) surges 50% in September, here’s what contributed to cryptocurrency price Quant Network’s QNT rose 50% in September, climbing in value from $87...
Month : September 2022
ATTENTION SOCIAL MEDIA USERS: New IFPMA and EFPIA Guidance on use of social media
The international and European self-regulatory bodies for the research-based pharmaceutical industry (IFPMA, International Federation of Pharmaceutical Manufacturers and Associations and EFPIA, European Federation of Pharmaceutical...
XRP Lawsuit: Former SEC Official’s Calendar Might Suggest Ripple Was Unfairly Targeted: Fox Business
As reported by Eleanor Terrett and Charles Gasparino on Fox Business, the meeting schedule of former SEC official William Hinman offers a thorough look into the...
Finding Assistance in Becoming a Citizen
In most countries, it is not very difficult to become a citizen. If a person is born to a father and/or mother who is a...
DOJ Helps Immigration Judges with Virtual Hearings
The DOJ has issued a memo on Internet hearings and sets forth guidelines to be applied to such hearings in immigration courts in the future....
Information on Form I-589 Intake and Processing Delays
July 28, 2022 USCIS is currently experiencing delays in issuing receipts for Form I-589, Application for Asylum and for Withholding of Removal. Due to these...
NOVEMBER 2021 RETAIL PATENT LITIGATION REPORT
After a break, I am back at the monthly patent litigation reports starting with catching up on some of the backlog. As usual, the NPEs...
Confidential: How to keep your amazing invention a secret
As an inventor, you know that your ideas are valuable. You also know that in order to maintain a competitive edge, you need to keep...
Still Got Bags of DOGE, Waiting for Price to Go Parabolic: David Gokhshtein
Yuri Molchan Crypto influencer David Gokhshtein has revealed that he still holds tons of Dogecoin In a recent tweet, founder of Gokhshtein Media, crypto enthusiast...
Court Denies Motion to Dismiss Claims Targeting a Biologic
The decision we report on today, Frye v. Novartis Pharms. Corp., 2022 WL 4305656 (E.D. Ark. 2022), leaves us shaking our heads. The court denied...